Published in TB and Outbreaks Week, September 19th, 2000
Medical investigators at Shimane Medical University studied the role of free fatty acids and their reactions with both reactive oxygen intermediates (ROI) and reactive nitrogen intermediates (RNI) in their influence on the antimicrobial activity of macrophages. RNI and ROI are antimicrobial effectors.
They used any of four growth accelerants to treat M. tuberculosis infected macrophages: quinacrine, arachidonyl trifuloromethylketone,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.